Aspergillosis clinical trials at UC Davis

1 research study open to eligible people

Olorofim Aspergillus Infection Study
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
Sacramento 5389489, California 5332921 and other locations

Last updated: September 2024

Olorofim Aspergillus Infection Study